SXTC Stock Analysis: Buy, Sell, or Hold?
SXTC - China SXT Pharmaceuticals, Inc. Ordinary Shares
$4.10
0.47 (12.95%)
▲
5d:
-5.31%
30d:
+1132.71%
90d:
+150.0%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Oct 07, 2026
Get Alerted When SXTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SXTC is 11.1% above its trading range ($3.69). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SXTC is 11.1% above its trading range ($3.69). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SXTC is currently trading at $4.10, which is considered extended relative to its 30-day fair value range of $0.31 to $3.69.
Technical Outlook: Technically, SXTC is showing sideways momentum. Immediate support is located at $3.10, while resistance sits at $5.55. The stock is showing strong short-term momentum, up 12.9% recently.
Market Sentiment: SXTC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SXTC is showing sideways momentum. Immediate support is located at $3.10, while resistance sits at $5.55. The stock is showing strong short-term momentum, up 12.9% recently.
Market Sentiment: SXTC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.31 -
$3.69
Company Quality Score
35/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
5.9%
All Signals
- BEARISH: Price significantly overextended (+11.1% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: Strong upward momentum (+12.9%)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.31 -
$3.69
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.10
Resistance Level
$5.55
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Revenue Growth (YoY)
-43.9%
Earnings Growth (YoY)
42.6%
Share & Embed Analysis
Last updated: August 23, 2026 12:55 AM ET
Data refreshes hourly during market hours. Next update: 1:55 AM
Data refreshes hourly during market hours. Next update: 1:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SXTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 56 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 43 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$653 | 48 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 55 HOLD |
